glp 1 medications names Indications for GLP-1/GIP RA Summary Sheet and Beyond! Market Overview: GLP-1 Agonists and

Scope includes market sizing and forecasting for 2026 to 2036, segmentation by drug, indication, route of administration, distribution channel, and region, along with competitive assessment and pipeline analysis

These genetic predispositions may help provide context about individual metabolic biology and how the incretin system functions at a molecular level, supporting more personalized provider conversations about which mechanism classsingle GLP-1, dual GLP-1/GIP, or non-incretin alternativesmight align with genetic pathway activity

For some patients, these medications may offer benefits that extend beyond blood sugar control, particularly in optimizing conditions that support reproductive health

Patients are assessed to determine the most appropriate semaglutide format based on medical history, tolerance, and treatment objectives

doi: 10.1002/iub.2046 129 VinuNavarroJHerrero-CerveraAGarca-CubasMAndrs-BlascoIMartnez-HervsSet al

These include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort